Bacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats

dc.contributor.authorMartín Hernández, David
dc.contributor.authorCaso Fernández, Javier Rubén
dc.contributor.authorGonzález Bris, Álvaro
dc.contributor.authorMaus, Sandra R.
dc.contributor.authorMuñoz Madrigal, José Luis
dc.contributor.authorGarcía Bueno, Borja
dc.contributor.authorMac-Dowell Mata, Karina Soledad
dc.contributor.authorAlou Cervera, Luis
dc.contributor.authorGómez-Lus Centelles, María Luisa
dc.contributor.authorLeza Cerro, Juan Carlos
dc.date.accessioned2024-07-19T09:35:28Z
dc.date.available2024-07-19T09:35:28Z
dc.date.issued2015-12-11
dc.description.abstractRecent studies have suggested that depression is accompanied by an increased intestinal permeability which would be related to the inflammatory pathophysiology of the disease. This study aimed to evaluate whether experimental depression presents with bacterial translocation that in turn can lead to the TLR-4 in the brain affecting the mitogen-activated protein kinases (MAPK) and antioxidant pathways. Male Wistar rats were exposed to chronic mild stress (CMS) and the intestinal integrity, presence of bacteria in tissues and plasma lipopolysaccharide levels were analyzed. We also studied the expression in the prefrontal cortex of activated forms of MAPK and some of their activation controllers and the effects of CMS on the antioxidant Nrf2 pathway. Our results indicate that after exposure to a CMS protocol there is increased intestinal permeability and bacterial translocation. CMS also increases the expression of the activated form of the MAPK p38 while decreasing the expression of the antioxidant transcription factor Nrf2. The actions of antibiotic administration to prevent bacterial translocation on elements of the MAPK and Nrf2 pathways indicate that the translocated bacteria are playing a role in these effects. In effect, our results propose a role of the translocated bacteria in the pathophysiology of depression through the p38 MAPK pathway which could aggravate the neuroinflammation and the oxidative/nitrosative damage present in this pathology. Moreover, our results reveal that the antioxidant factor Nrf2 and its activators may be involved in the consequences of the CMS on the brain
dc.description.departmentDepto. de Farmacología y Toxicología
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipInstituto de Salud Carlos III
dc.description.sponsorshipCIBERSAM
dc.description.sponsorshipFundación Mutua Madrileña
dc.description.statuspub
dc.identifier.citationMartín-Hernández D, Caso JR, Bris ÁG, Maus SR, Madrigal JL, García-Bueno B, MacDowell KS, Alou L, Gómez-Lus ML, Leza JC. Bacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats. Neuropharmacology. 2016 Apr;103:122-33
dc.identifier.doi10.1016/j.neuropharm.2015.12.003
dc.identifier.issn0028-3908
dc.identifier.officialurlhttps://doi.org/10.1016/j.neuropharm.2015.12.003
dc.identifier.urihttps://hdl.handle.net/20.500.14352/106880
dc.journal.titleNeuropharmacology
dc.language.isoeng
dc.page.final133
dc.page.initial122
dc.publisherElsevier
dc.relation.projectIDFIS PI10/00123
dc.relation.projectIDFIS PI13/01102
dc.rights.accessRightsrestricted access
dc.subject.cdu611.02
dc.subject.cdu615
dc.subject.cdu616.8
dc.subject.keywordBacterial translocation
dc.subject.keywordDUSPs
dc.subject.keywordDepression
dc.subject.keywordMitogen-activated protein kinases
dc.subject.keywordOxidative damage
dc.subject.keywordTranscription factor Nrf2
dc.subject.ucmFarmacología (Medicina)
dc.subject.ucmMicrobiología médica
dc.subject.ucmNeurociencias (Medicina)
dc.subject.unesco2414 Microbiología
dc.subject.unesco3209 Farmacología
dc.subject.unesco3205.07 Neurología
dc.titleBacterial translocation affects intracellular neuroinflammatory pathways in a depression-like model in rats
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number103
dspace.entity.typePublication
relation.isAuthorOfPublication4b8ce4a4-fb5a-4b64-9a2f-460a47e60741
relation.isAuthorOfPublicationf33a88b3-a5e1-4217-91d6-48fa85387a03
relation.isAuthorOfPublication6af34e23-e137-4fbd-9119-e470b9b2b600
relation.isAuthorOfPublication0c44d00b-2f15-4375-9aba-bbd0b931fcf4
relation.isAuthorOfPublicationd7de3e71-d141-4e63-ab4c-a71249846532
relation.isAuthorOfPublication889e4dc3-c630-429e-be0f-7f0df2cff492
relation.isAuthorOfPublicationf7ad336e-4779-4665-9893-44b47bed8a7a
relation.isAuthorOfPublication60ff0835-366b-4a2b-9c1e-4533824ea881
relation.isAuthorOfPublication.latestForDiscovery4b8ce4a4-fb5a-4b64-9a2f-460a47e60741

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2016 Neuropharm - Martin.pdf
Size:
1.91 MB
Format:
Adobe Portable Document Format

Collections